newsfilter
← Latest News
GlobeNewswire·

AN2 Therapeutics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

BOSTON, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating AN2 Therapeutics, Inc. (NASDAQ:ANTX) for potential securities law violations. Investors who have lost money in their AN2 Therapeutics, Inc.